At Genentech BioOncology, we’re dedicated to fundamentally changing the way cancer is treated. Our commitment to this goal has enabled us to make significant contributions to the understanding of cancer and to translate this understanding into targeted, biologic-based therapies.
Genentech’s BioOncology application provides all health care professionals with free access to the latest oncology news, resources and innovation.
Key features include:
- News: Read up-to-date oncology news from Reuters Health
- Research Focus: Learn more about Genentech’s innovative compounds designed to target cancer through specific molecular processes
- Clinical Trials: Find Genentech and non-Genentech clinical trials based on tumor type, and access details including objectives, outcome measures and protocol entry criteria
- Polls: Participate in oncology-related polls and view live results
- Contact Us: Reach out to Genentech anytime, day or night, from one simple form
And coming soon:
- Useful Resource Links
- Grants, Contributions & Fellowships
From Genentech, a member of the Roche Group